MedPath

Surgical Margin Assessment by 3D Ultrasound

Not Applicable
Recruiting
Conditions
Head and Neck Cancer
Tongue Cancer
Squamous Cell Carcinoma
Interventions
Diagnostic Test: 3D ultrasound
Registration Number
NCT05740774
Lead Sponsor
Rigshospitalet, Denmark
Brief Summary

Complete removal of cancer encircled by a secure margin of healthy tissue is the aim of surgical oncology. A close or positive surgical margin reported by pathologist typically ends in adjuvant therapies (re-surgery and/or radiotherapy), which come with prognostic risks and financial cost. Therefore, ex-vivo imaging of removed cancer tissue may assist in margin evaluation. In this study, investigators aimed to investigate the correlation of 3D ultrasound to histopathology to assess tongue tumor margin status.

Detailed Description

Not available

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
7
Inclusion Criteria
  • Patients with biopsy-proven oral tongue squamous cell carcinoma scheduled for surgical treatment
  • T1-T2 staging on cross-sectional imaging
Exclusion Criteria
  • Age < 18 yrs
  • T3-T4 staging
  • Unable to understand the verbal or written information
  • Prior radiotherapy treatment of oral cavity cancer

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
Tongue tumor resection3D ultrasound-
Primary Outcome Measures
NameTimeMethod
Correlation of the surgical margin measurements of the 3D ultrasound to histopathology2 weeks

The smallest margin will be measured in mm on 3D ultrasound image of the ex-vivo surgical specimen. Correlation of the measurement to the final histopathology result will be investigated.

Diagnostic accuracy2 weeks

number of margins correctly classified as free (\> 5 mm), close (\< 5 mm) or positive (\<1 mm) margin

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Rigshospitalet

🇩🇰

København Ø, Dk-015, Denmark

© Copyright 2025. All Rights Reserved by MedPath